TKT and glioblastoma: Recently, Tamura and colleagues evaluated the efficacy of a LV encoding HSV-TK under the control of a tet-inducible system for the treatment of GBM using neural stem/progenitor cells (NS/PCs) derived from induced pluripotent stem cells (hiPSCs).